| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.07 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.07 |